PDGFRB and Familial prostate cancer: A DCE-MRI study assessing anti-PDGFR therapy effects in a prostate cancer bone metastasis model with biotin-labeled albumin-Gd-DTPA showed a reduction in vascular permeability and provided insights into the role played by VEGF in anti-PDGFR therapy [57].